Combination immunotherapy with α-CTLA-4 and α-PD-L1 antibody blockade prevents immune escape and leads to complete control of metastatic osteosarcoma
Crossref DOI link: https://doi.org/10.1186/s40425-015-0067-z
Published Online: 2015-05-19
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lussier, Danielle M
Johnson, John L
Hingorani, Pooja
Blattman, Joseph N https://orcid.org/0000-0003-2504-9663
Funding for this research was provided by:
Hyundai Hope On Wheels (0000-0003-2504-9663)
License valid from 2015-05-19